Brixton Biosciences

Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain. The company’s treatment approach involves "freezing" pain through a simple injection, designed to induce reversible neural inhibition and provide longer-lasting pain relief than current methods, enabling patients to experience 30 to 60 days of pain relief with a single injection.